https://www.selleckchem.com/pr....oducts/bos172722.htm
Beyond the technical challenges, heart valve tissue engineering faces logistical, economic, and regulatory challenges. In this review, we summarise recent progress in heart valve tissue engineering, highlight important outcomes from preclinical and clinical testing, and discuss challenges and future directions toward clinical translation. One of the most common fetal complications in pregnant women with cardiovascular disease is small for gestational age (SGA) which is associated with a higher risk of perinatal morbidity/mortality and
Like
Comment
Share
